Platform evolution
Live demoA route from study execution to portfolio decisions, with one governed delivery plan.
Clinical systems / 01
A synthetic sponsor portfolio, designed as a connected data and reporting system. Follow how operational feeds become governed data products, shared measures and decisions a study team can inspect.
System flow / 02
Raw source feeds (EDC, CTMS, IRT, eTMF, finance, a legacy export), kept as received.
Conformed, quality-checked data products, each under a versioned contract.
Star-schema marts for operations, portfolio and RBQM, plus SDTM and ADaM from the Study Data Pipeline.
Governed metrics compiled once for every consumer.
Dashboards, SQL, BI and reviewable evidence.
Governance, quality, lineage and validation evidence span every layer. The gold layer's SDTM and ADaM come from the Study Data Pipeline, which you can run and trace end to end.
Evidence index / 03
Live links open working demonstrations. Planned links open the issue that defines the next artifact.
A route from study execution to portfolio decisions, with one governed delivery plan.
Versioned contracts, conformed marts, one metric definition per business question.
Collection, tabulation and analysis connected by study metadata and lineage.
An AWS reference design, deployment boundaries and cost decisions for an architecture review.
Legacy reconciliation, cutover and standards-based inbound adapters.
Stewardship, quality rules, column lineage and risk-based validation evidence.
Study and portfolio measures with drill-down and accessible table equivalents.
Weighted evaluation, build versus buy, five-year cost and decision memos.
A migration lab and case study connect design decisions to an operating model.
Operating model, adoption measures and a modernization case study.
A query workbench, cross-engine SQL checks and a text-based BI model.
Control mappings and evidence that can be inspected without claiming validation.
One synthetic portfolio spanning pharmaceutical, device and outsourced studies.